These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 8240284)

  • 21. Differences between platelet and microparticle glycoprotein IIb/IIIa.
    Nomura S; Suzuki M; Kido H; Yamaguchi K; Fukuroi T; Yanabu M; Soga T; Nagata H; Kokawa T; Yasunaga K
    Cytometry; 1992; 13(6):621-9. PubMed ID: 1451594
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Studies of activated GPIIb/IIIa receptors on the luminal surface of adherent platelets. Paradoxical loss of luminal receptors when platelets adhere to high density fibrinogen.
    Coller BS; Kutok JL; Scudder LE; Galanakis DK; West SM; Rudomen GS; Springer KT
    J Clin Invest; 1993 Dec; 92(6):2796-806. PubMed ID: 8254034
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dynamics of platelet glycoprotein IIb-IIIa receptor expression and fibrinogen binding. I. Quantal activation of platelet subpopulations varies with adenosine diphosphate concentration.
    Frojmovic MM; Mooney RF; Wong T
    Biophys J; 1994 Nov; 67(5):2060-8. PubMed ID: 7858143
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Calcium binding to human platelet integrin GPIIb/IIIa and to its constituent glycoproteins. Effects of lipids and temperature.
    Rivas GA; González-Rodríguez J
    Biochem J; 1991 May; 276 ( Pt 1)(Pt 1):35-40. PubMed ID: 2039481
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Autoantibodies against the platelet glycoproteins (GP) IIb/IIIa, Ia/IIa, and IV and partial deficiency in GPIV in a patient with a bleeding disorder and a defective platelet collagen interaction.
    Beer JH; Rabaglio M; Berchtold P; von Felten A; Clemetson KJ; Tsakiris DA; Kehrel B; Brandenberger S
    Blood; 1993 Aug; 82(3):820-9. PubMed ID: 7687896
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of ATP on ligand recognition of platelet fibrinogen receptor on GPIIb-IIIa.
    Gawaz MP; Mayinger P; Neumann FJ
    Am J Physiol; 1994 Sep; 267(3 Pt 2):H1098-106. PubMed ID: 8092274
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Endogenous platelet fibrinogen surface expression on activated platelets.
    Gralnick HR; Williams S; McKeown L; Connaghan G; Shafer B; Hansmann K; Vail M; Fenton J
    J Lab Clin Med; 1991 Dec; 118(6):604-13. PubMed ID: 1744509
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of thrombospondin in platelet aggregation.
    Leung LL
    J Clin Invest; 1984 Nov; 74(5):1764-72. PubMed ID: 6501568
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Divalent cation regulation of the surface orientation of platelet membrane glycoprotein IIb. Correlation with fibrinogen binding function and definition of a novel variant of Glanzmann's thrombasthenia.
    Ginsberg MH; Lightsey A; Kunicki TJ; Kaufmann A; Marguerie G; Plow EF
    J Clin Invest; 1986 Oct; 78(4):1103-11. PubMed ID: 2428841
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Thrombospondin as an agglutinin of platelets.
    Satoh S; Takahashi K; Sakuragawa N
    Thromb Res; 1993 Dec; 72(6):509-17. PubMed ID: 8128455
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of integrin-mediated platelet aggregation, fibrinogen-binding, and interactions with extracellular matrix by nonpeptidic mimetics of Arg-Gly-Asp.
    Varon D; Lider O; Dardik R; Shenkman B; Alon R; Hershkoviz R; Kapustina G; Savion N; Martinowitz U; Greenspoon N
    Thromb Haemost; 1993 Dec; 70(6):1030-6. PubMed ID: 8165596
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Thrombospondin binds to the surface of human osteosarcoma cells and mediates platelet-osteosarcoma cell interaction.
    Clezardin P; Serre CM; Trzeciak MC; Drouin J; Delmas PD
    Cancer Res; 1991 May; 51(10):2621-7. PubMed ID: 1708697
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A monoclonal antibody to the human platelet glycoprotein IIb/IIIa complex induces platelet activation.
    Modderman PW; Huisman HG; van Mourik JA; von dem Borne AE
    Thromb Haemost; 1988 Aug; 60(1):68-74. PubMed ID: 2973154
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Asialo von Willebrand factor interactions with platelets. Interdependence of glycoproteins Ib and IIb/IIIa for binding and aggregation.
    Grainick HR; Williams SB; Coller BS
    J Clin Invest; 1985 Jan; 75(1):19-25. PubMed ID: 2981249
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CD36 peptides enhance or inhibit CD36-thrombospondin binding. A two-step process of ligand-receptor interaction.
    Leung LL; Li WX; McGregor JL; Albrecht G; Howard RJ
    J Biol Chem; 1992 Sep; 267(25):18244-50. PubMed ID: 1381367
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Protein-tyrosine phosphorylation and p72syk activation in human platelets stimulated with collagen is dependent upon glycoprotein Ia/IIa and actin polymerization.
    Asazuma N; Yatomi Y; Ozaki Y; Qi R; Kuroda K; Satoh K; Kume S
    Thromb Haemost; 1996 Apr; 75(4):648-54. PubMed ID: 8743194
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Thrombospondin-platelet interactions. Role of divalent cations, wall shear rate, and platelet membrane glycoproteins.
    Agbanyo FR; Sixma JJ; de Groot PG; Languino LR; Plow EF
    J Clin Invest; 1993 Jul; 92(1):288-96. PubMed ID: 7686921
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Conformational changes of the platelet membrane glycoprotein IIb-IIIa complex stimulated by a monoclonal antibody to the N-terminal segment of glycoprotein IIIa].
    Khaspekova SG; Vyzova TV; Lukin VV; Tikhomirov OIu; Berndt M; Kouns W; Mazurov AV
    Biokhimiia; 1996 Mar; 61(3):412-28. PubMed ID: 8724599
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Independent modulation of von Willebrand factor and fibrinogen binding to the platelet membrane glycoprotein IIb/IIIa complex as demonstrated by monoclonal antibody.
    Lombardo VT; Hodson E; Roberts JR; Kunicki TJ; Zimmerman TS; Ruggeri ZM
    J Clin Invest; 1985 Nov; 76(5):1950-8. PubMed ID: 2414325
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differential inhibition of fibrinogen binding to agonist- and RGDS peptide-activated states of GPIIb-IIIa by an anti-GPIIIa monoclonal antibody, PMA5.
    Nakatanl S; Hato T; Minamoto Y; Fujita S
    Thromb Haemost; 1996 Dec; 76(6):1030-7. PubMed ID: 8972028
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.